Conditions: Allergic Conjunctivitis
Keywords: Allergic conjunctivitis
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 215
Healthy volunteers: no

Brief summary:
The purpose of this study is to evaluate patient perceptions of olopatadine 0.2% dosed once daily in patients previously treated with twice-daily, topical, ocular, anti-allergy medications.

Detailed description:

Arms:
arm 1: 1 drop self-administered in each eye once daily in the morning for 7 days

Interventions: intervention 1: Olopatadine hydrochloride ophthalmic solution, 0.2% (Pataday®)
Intervention descriptions: intervention 1: Commercially marketed ophthalmic solution for the treatment of ocular itching associated with allergic conjunctivitis

Protocol document: